ABSTRACT
Endometrial cancer is now the most common gynaecological malignancy in the Western world, having surpassed ovarian cancer over the last 10 years. 1 It is the seventh commonest cancer in women and the most common gynaecological malignancy in the developed world. 2 The incidence is increasing due to a rising level of obesity, diabetes mellitus, an increasing ageing population and the use of oestrogenic drugs, which predispose towards disease onset and progression. Approximately 10% of cancers occur in women less than 50 years of age. 3 Traditionally it is thought that endometrial cancer, due to its earlier recognition, has a better prognosis than the other gynaecological malignancies. To an extent this is true, as it has an overall 5–year survival of ~75%.
